Case ReportTransfemoral Access for Valve in Valve Implantation of an Edwards Sapien XT Valve in a Stenotic Tricuspid Bioprosthesis Under Fluoroscopic Guidance
Section snippets
Case Report
Transcatheter valve-in-valve strategies for degenerated bioprostheses are increasingly used because repeat surgery implies an elevated risk and technical challenges. Here, we report the case of a 53-year-old male patient with progressive interstitial lung disease because of hypersensitivity pneumonitis. Recently, a high-grade stenosis was diagnosed in the tricuspid bioprosthesis (Shelhigh NR900A, 31 mm), which was implanted in the year 2004 because of postendocarditic regurgitation. Tricuspid
Discussion
Valve-in-valve strategies are being increasingly applied as a remedy for degenerated bioprostheses. Though valve-in-valve strategies have been preferentially used in degenerated aortic bioprostheses, few publications exist for degenerated tricuspid bioprostheses. Implantation via the transjugular,1, 2 trans-atrial,3 and transfemoral4 access routes has been reported. However, this is the first report of valve-in-valve implantation in a degenerated tricuspid bioprostheses using local anaesthesia
Disclosures
The authors have no conflicts of interest to disclose.
References (5)
- et al.
Transjugular tricuspid valve-in-valve implantation: a safe and effective approach
Ann Thorac Surg
(2011) - et al.
Transatrial transcatheter tricuspid valve-in-valve implantation of balloon expandable bioprosthesis
Ann Thorac Surg
(2010)
Cited by (0)
See page 1014.e4 for disclosure information.